Evidence map›Paper›PMID 23842598›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2013

Emerging evidence on the pathobiology of mucositis.

Noor Al-Dasooqi, Stephen T Sonis, Joanne M Bowen, Emma Bateman, Nicole Blijlevens, Rachel J Gibson, Richard M Logan, Raj G Nair, Andrea M Stringer, Roger Yazbeck and 3 more

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 237 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Trial
  6. Reporting quality and spin in abstracts of randomized clinical trials related to oral mucositis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis.Current treatment options in oncology · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Noor Al-DasooqiDiscipline of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5000, Australia, noor.al-dasooqi@adelaide.edu.au.
Stephen T Sonis
Joanne M Bowen
Emma Bateman
Nicole Blijlevens
Rachel J Gibson
Richard M Logan
Raj G Nair
Andrea M Stringer
Roger Yazbeck
Sharon Elad
Rajesh V Lalla
Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
University of Adelaide · AUUniversity of South Australia · AUDana-Farber Cancer Institute · USEastman Chemical Company (United States) · USQueensland Health · AURadboud University Medical Center · NLUConn Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsiderable progress has been made in our understanding of the biological basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of the subject by MASCC/ISOO was published in 2007; consequently, an update is timely.

methodsPanel members reviewed the biomedical literature on mucositis pathobiology published between January 2005 and December 2011.

resultsRecent research has provided data on the contribution of tissue structure changes, inflammation and microbiome changes to the development of mucositis. Additional research has focused on targeted therapy-induced toxicity, toxicity clustering and the investigation of genetic polymorphisms in toxicity prediction. This review paper summarizes the recent evidence on these aspects of mucositis pathobiology.

conclusionThe ultimate goal of mucositis researchers is to identify the most appropriate targets for therapeutic interventions and to be able to predict toxicity risk and personalize interventions to genetically suitable patients. Continuing research efforts are needed to further our understanding of mucositis pathobiology and the pharmacogenomics of toxicity.

Indexed as

StomatitisAntineoplastic AgentsChemoradiotherapyEvidence-Based MedicineHead and Neck NeoplasmsHumansPharmacogeneticsAntineoplastic Agents

Identifiers

PMID23842598
OpenAlexW2116347275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.